Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

TRIM11 inhibits USP14. 3 / 3

| 3

➶

reach

"11) strongly reduced the deubiquitinase activity in the control lysates, and rendered TRIM11 ineffective in reducing deubiquitinase activity, indicating that TRIM11 specifically inhibits the deubiquitinase activity of USP14."

29581427

➶

reach

"Together, these results show that TRIM11 inhibits the association of USP14 with PSMD2, preventing it from docking on the proteasome."

29581427

➶

reach

"By displacing USP14, TRIM11 changes proteasome composition and suppresses both catalytic and non catalytic effects of USP14."

29581427

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

TRIM11 inhibits USP14. 3 / 3

Our Sources:

Databases

Reading